Sign in
4

Changes in Ownership

Alaunos Therapeutics, Inc. Filed Acc 0000950170-25-090589

Options or other derivatives

  • Director bought 250 shares at $4.49 ($1,123)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Vieser Jaime Director 2025-06-24 Purchase · Series A-2 Convertible Preferred Stock +250 $4.49 $1,123 250 D
Loading xslF345X05/ownership.xml…